| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Product containing rituximab (medicinal product) | Has active ingredient | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| rituximab 10 mg/ml, injektionskoncentrat, flaska 10 ml | Has active ingredient | False | Rituximab (substance) | Inferred relationship | Some |  | 
| rituximab 10 mg/ml, infusionskoncentrat, flaska 50 ml | Has active ingredient | False | Rituximab (substance) | Inferred relationship | Some |  | 
| Rituximab 500mg infusion concentrate vial | Has active ingredient | False | Rituximab (substance) | Inferred relationship | Some |  | 
| Rituximab 100mg infusion concentrate vial | Has active ingredient | False | Rituximab (substance) | Inferred relationship | Some |  | 
| Adverse reaction to rituximab administered by infusion | Causative agent | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| Product containing rituximab in parenteral dose form (medicinal product form) | Has active ingredient | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Direct substance | True | Rituximab (substance) | Inferred relationship | Some | 7 | 
| Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy) | Direct substance | True | Rituximab (substance) | Inferred relationship | Some | 6 | 
| Rituximab therapy (procedure) | Direct substance | True | Rituximab (substance) | Inferred relationship | Some | 2 | 
| rituximab 100 mg/10 ml, infusionsvätska, lösning, flaska | Has basis of strength substance (attribute) | False | Rituximab (substance) | Inferred relationship | Some | 1 | 
| rituximab 100 mg/10 ml, infusionsvätska, lösning, flaska | Has precise active ingredient | False | Rituximab (substance) | Inferred relationship | Some | 1 | 
| rituximab 500 mg/50 ml, infusionsvätska, lösning, flaska | Has basis of strength substance (attribute) | False | Rituximab (substance) | Inferred relationship | Some | 1 | 
| rituximab 500 mg/50 ml, infusionsvätska, lösning, flaska | Has precise active ingredient | False | Rituximab (substance) | Inferred relationship | Some | 1 | 
| Rituximab only product | Has active ingredient | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| Rituximab only product in parenteral dose form | Has active ingredient | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Has precise active ingredient | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Has basis of strength substance (attribute) | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Direct substance | True | Rituximab (substance) | Inferred relationship | Some | 2 | 
| Rituximab 10 mg/mL solution for injection | Has precise active ingredient | True | Rituximab (substance) | Inferred relationship | Some | 1 | 
| Rituximab 10 mg/mL solution for injection | Has basis of strength substance (attribute) | True | Rituximab (substance) | Inferred relationship | Some | 1 |